⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVCR News
NovoCure Limited Ordinary Shares
Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress
businesswire.com
NVCR
Novocure to Report Third Quarter 2025 Financial Results
businesswire.com
NVCR
Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting
businesswire.com
NVCR